Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
608.4 GBX | -1.23% | -1.55% | -5.23% |
Sales 2022 | -13.58M -17.03M | Sales 2023 | 10.47M 13.13M | Capitalization | 253M 317M |
---|---|---|---|---|---|
Net income 2022 | -22M -27.58M | Net income 2023 | 6M 7.52M | EV / Sales 2022 | -22.5 x |
Net Debt 2022 | 39.98M 50.12M | Net Debt 2023 | 32.47M 40.71M | EV / Sales 2023 | 27.3 x |
P/E ratio 2022 |
-11.9
x | P/E ratio 2023 |
38.4
x | Employees | - |
Yield 2022 |
4.83% | Yield 2023 |
4.38% | Free-Float | 90.83% |
Latest transcript on International Biotechnology Trust plc
1 day | -1.23% | ||
1 week | -1.55% | ||
Current month | -7.26% | ||
1 month | -5.38% | ||
3 months | -7.26% | ||
6 months | +9.82% | ||
Current year | -5.23% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Investment Officer | 47 | - | |
Jonathan Mott
CMP | Compliance Officer | - | - |
Lucy Duarte
IRC | Investor Relations Contact | - | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 20-05-18 | |
Gillian Elcock
BRD | Director/Board Member | 51 | 23-01-31 |
Director/Board Member | 59 | 15-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 608.4 | -1.23% | 26 223 |
24-04-26 | 616 | +1.65% | 19,950 |
24-04-25 | 606 | -2.57% | 42,457 |
24-04-24 | 622 | -0.80% | 49,003 |
24-04-23 | 627 | +1.46% | 44,486 |
Delayed Quote London S.E., April 29, 2024 at 07:57 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.23% | 290M | |
+4.02% | 14.32B | |
+3.13% | 6.21B | |
+12.75% | 4.4B | |
+11.02% | 4.36B | |
-6.40% | 4B | |
+4.52% | 3.51B | |
+9.06% | 3.22B | |
+7.72% | 3.06B | |
-2.43% | 2.77B |
- Stock Market
- Equities
- IBT Stock